Honz Pharmaceutical Statistics

Total Valuation

SHE:300086 has a market cap or net worth of CNY 3.37 billion. The enterprise value is 3.78 billion.

Market Cap	3.37B
Enterprise Value	3.78B

Important Dates

The last earnings date was Wednesday, April 29, 2026.

Earnings Date	Apr 29, 2026
Ex-Dividend Date	n/a

Share Statistics

SHE:300086 has 455.12 million shares outstanding. The number of shares has increased by 0.84% in one year.

Current Share Class	455.12M
Shares Outstanding	455.12M
Shares Change (YoY)	+0.84%
Shares Change (QoQ)	+0.09%
Owned by Insiders (%)	4.22%
Owned by Institutions (%)	0.79%
Float	311.89M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	7.23
PB Ratio	3.66
P/TBV Ratio	4.07
P/FCF Ratio	115.65
P/OCF Ratio	27.78
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-16.41
EV / Sales	8.10
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	129.68

Financial Position

The company has a current ratio of 0.52, with a Debt / Equity ratio of 0.48.

Current Ratio	0.52
Quick Ratio	0.20
Debt / Equity	0.48
Debt / EBITDA	n/a
Debt / FCF	15.34
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -22.43% and return on invested capital (ROIC) is -11.23%.

Return on Equity (ROE)	-22.43%
Return on Assets (ROA)	-5.31%
Return on Invested Capital (ROIC)	-11.23%
Return on Capital Employed (ROCE)	-13.25%
Weighted Average Cost of Capital (WACC)	6.19%
Revenue Per Employee	707,318
Profits Per Employee	-349,224
Employee Count	659
Asset Turnover	0.25
Inventory Turnover	1.23

Taxes

Income Tax	-25.44M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +61.22% in the last 52 weeks. The beta is 0.50, so SHE:300086's price volatility has been lower than the market average.

Beta (5Y)	0.50
52-Week Price Change	+61.22%
50-Day Moving Average	8.38
200-Day Moving Average	8.72
Relative Strength Index (RSI)	42.64
Average Volume (20 Days)	39,518,650

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, SHE:300086 had revenue of CNY 466.12 million and -230.14 million in losses. Loss per share was -0.51.

Revenue	466.12M
Gross Profit	252.65M
Operating Income	-160.04M
Pretax Income	-259.47M
Net Income	-230.14M
EBITDA	-93.17M
EBIT	-160.04M
Loss Per Share	-0.51

Full Income Statement

Balance Sheet

The company has 59.75 million in cash and 446.69 million in debt, giving a net cash position of -386.94 million or -0.85 per share.

Cash & Cash Equivalents	59.75M
Total Debt	446.69M
Net Cash	-386.94M
Net Cash Per Share	-0.85
Equity (Book Value)	921.22M
Book Value Per Share	1.98
Working Capital	-279.01M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 121.24 million and capital expenditures -92.12 million, giving a free cash flow of 29.12 million.

Operating Cash Flow	121.24M
Capital Expenditures	-92.12M
Depreciation & Amortization	66.88M
Net Borrowing	-61.44M
Free Cash Flow	29.12M
FCF Per Share	0.06

Full Cash Flow Statement

Margins

Gross margin is 54.20%, with operating and profit margins of -34.34% and -49.37%.

Gross Margin	54.20%
Operating Margin	-34.34%
Pretax Margin	-55.67%
Profit Margin	-49.37%
EBITDA Margin	-19.99%
EBIT Margin	-34.34%
FCF Margin	6.25%

Dividends & Yields

SHE:300086 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.84%
Shareholder Yield	-0.84%
Earnings Yield	-6.83%
FCF Yield	0.86%

Dividend Details

Stock Splits

The last stock split was on September 30, 2015. It was a forward split with a ratio of 1.5.

Last Split Date	Sep 30, 2015
Split Type	Forward
Split Ratio	1.5

Scores

Altman Z-Score	n/a
Piotroski F-Score	3